Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics
- PMID: 28700424
- DOI: 10.1097/PGP.0000000000000346
Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics
Abstract
Carcinosarcomas (malignant mixed Müllerian tumors or MMMT) are rare malignant tumors in the female genital tract composed of both malignant epithelial and malignant mesenchymal components. They comprise <5% of all neoplasms in the gynecologic tract and have an aggressive clinical course. The purpose of this study is to evaluate the immunophenotype and possible histogenesis of carcinosarcomas of the uterus. Sixty-two cases of uterine carcinosarcomas diagnosed between 1995 and 2011 were retrieved from the gynecologic pathology files at Columbia University Medical Center. Representative tissue blocks containing both epithelial and mesenchymal components were selected from each case for histologic and immunohistochemical studies. Clinical data from each case were retrieved. The epithelial component was poorly differentiated adenocarcinoma in the majority (80.7%) of cases; in 17.7%, the carcinoma was moderately differentiated, and in only 1.6% the carcinoma was well differentiated. 53% of the tumors had homologous stromal elements and 47% displayed heterologous stromal elements. Immunohistochemical study revealed almost equal staining in both epithelial and mesenchymal components of carcinosarcomas for p16 and p53. PAX8 positivity was noted in 73% of epithelial components, but only 13% of stromal components, and PAX8 stromal positivity was never seen in the absence of PAX8 epithelial positivity. Expression of p16, p53, and PAX8 in both malignant components lends support to the monoclonal theory of uterine carcinosarcoma tumorigenesis. The roles of these tumor markers in the diagnosis and pathogenesis of this tumor and associations between clinical characteristics, tumor pathologic features, and prognosis are discussed.
Similar articles
-
PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.Appl Immunohistochem Mol Morphol. 2018 Jul;26(6):393-397. doi: 10.1097/PAI.0000000000000457. Appl Immunohistochem Mol Morphol. 2018. PMID: 27801734
-
Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.J Natl Compr Canc Netw. 2009 May;7(5):550-6; quiz 557. doi: 10.6004/jnccn.2009.0037. J Natl Compr Canc Netw. 2009. PMID: 19460280 Review.
-
CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):293-9. Appl Immunohistochem Mol Morphol. 2000. PMID: 11127921
-
PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma).Int J Gynecol Pathol. 2014 Jul;33(4):425-31. doi: 10.1097/PGP.0b013e31829d7705. Int J Gynecol Pathol. 2014. PMID: 24901404
-
Uterine Carcinosarcomas - Diagnosis and Management.Oncol Res Treat. 2018;41(11):675-679. doi: 10.1159/000494335. Epub 2018 Oct 13. Oncol Res Treat. 2018. PMID: 30317231 Review.
Cited by
-
Uterine carcinosarcoma (malignant mixed Müllerian tumor): case report in a goat and literature review.J Vet Diagn Invest. 2018 Nov;30(6):955-961. doi: 10.1177/1040638718808341. Epub 2018 Oct 21. J Vet Diagn Invest. 2018. PMID: 30345891 Free PMC article.
-
Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas.Pathol Oncol Res. 2023 Dec 11;29:1611547. doi: 10.3389/pore.2023.1611547. eCollection 2023. Pathol Oncol Res. 2023. PMID: 38146588 Free PMC article.
-
TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.Pathol Oncol Res. 2020 Oct;26(4):2067-2073. doi: 10.1007/s12253-020-00829-9. Epub 2020 May 29. Pathol Oncol Res. 2020. PMID: 32472441
-
Surgical staging identifies occult metastases in over 50% of uterine-confined carcinosarcoma.Gynecol Oncol Rep. 2025 Mar 18;58:101722. doi: 10.1016/j.gore.2025.101722. eCollection 2025 Apr. Gynecol Oncol Rep. 2025. PMID: 40176852 Free PMC article.
-
Uterine carcinosarcoma with heterologous osseous elements: a case report of an extremely rare clinical occurrence with literature review.Front Oncol. 2025 Feb 14;15:1505504. doi: 10.3389/fonc.2025.1505504. eCollection 2025. Front Oncol. 2025. PMID: 40027125 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous